In contrast, destructive glomerular diseases such as diabetic nephropathy (DN), focal segmental glomerulosclerosis (FSGS), and collapsing FSGS (cFSGS) showed reduced levels of ARHGAP29 expression. Here, ARHGAP29 is linked to focal segmental glomerulosclerosis.